Fractyl Health, Inc. (GUTS) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

10/25

Growth 2 Margin 2 Expansion 3 Platform 1 Financial 2

latest quarter score

Earnings Reports

10
Fractyl Health (GUTS) Q2 2026: 80% Weight Loss Maintenance Signals Strong Path to FDA Submission
August 11, 2026
8
Fractal (GUTS) Q1 2026: Pivotal Trial Progress Sets Up Three Data Catalysts Into Year-End
May 13, 2026
10
Fractal Health (GUTS) Q4 2025: 16cm Ablation Threshold Sharpens Pivotal Success Odds
March 25, 2026
10
Fractal Health (GUTS) Q3 2025: Revita Delivers 9% Two-Year Weight Loss, Defining Post-GLP-1 Maintenance Market
November 13, 2025
10
Fractal Health (GUTS) Q2 2025: $23M Capital Raise Extends Runway Through Critical Revita Data Milestones
August 12, 2025
6
Fractyl Health (GUTS) Q1 2025: REMAIN-1 Enrollment Ahead by 3 Months, Accelerating Weight Maintenance Leadership
May 13, 2025
Fractyl Health (GUTS) Q4 2024: REMAIN-1 Study Enrollment Surpasses 189 Patients, Signaling Strong Demand for Weight Maintenance Solutions
March 03, 2025

Browse all companies